Contact
The EDDU (Early Drug Discovery Unit) is a unit of the University of Barcelona that specializes in the early phases of drug discovery, with technological capabilities in computational design, organic synthesis and development of biophysical assays.
Universitat de Barcelona (UB)
Virtual scanning, ligandability, medicinal chemistry, hit-to-lead, organic synthesis, API synthesis, impurity characterization, assay development, biophysical techniques, intellectual protection, degraders, allosteric modulators
Want more information about TECNIO Technology Developers?
Technological capabilities
- Computational screening with molecular simulations and evaluation of "ligandability" using our own clusters with NVIDIA GPUs and access to supercomputing (CSUC/BSC).
- Advanced synthesis of APIs and optimization of industrial processes with laboratories equipped with LC-MS and infrastructure for hazardous reactions.
- Development of biophysical (SPR, ITC, DSF) and enzymatic assays with specialized equipment such as the AKTA system for protein purification.
- Characterization of pharmaceutical impurities and analytical validation according to ICH Q2 regulations. Patent evaluation and consulting on intellectual property strategies, with experience as experts in pharmaceutical litigation. Design of drugs with innovative mechanisms such as protein degraders or allosteric modulators, with international patents licensed to startups such as Oniria Therapeutics.
TOPTechnological fields
Biotechnology, Omics, Design new drugs / vaccines
Foodtech
Relevant equipment
- Computational clusters with 44 NVIDIA GPUs.
- Access to high-resolution NMR (600-1000 MHz).
- Organic synthesis laboratory with LC-MS.
EDDU location
